Clinical Trials List
Protocol Number018-00
Not yet recruiting
2006-02-01 - 2008-06-01
Phase III
Terminated3
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- Szu-Min Hsieh Division of Infectious Disease
- 陳茂源 Division of Rheumatology
- Wang-Huei Sheng Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
345 participants
